Huron Consulting Group Inc. $HURN Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC trimmed its holdings in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 20.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 52,312 shares of the business services provider’s stock after selling 13,370 shares during the quarter. Janus Henderson Group PLC’s holdings in Huron Consulting Group were worth $6,670,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the business. Fiduciary Management Inc. WI acquired a new position in shares of Huron Consulting Group during the 4th quarter valued at $90,661,000. UBS Group AG raised its position in Huron Consulting Group by 271.0% in the fourth quarter. UBS Group AG now owns 422,719 shares of the business services provider’s stock valued at $73,092,000 after purchasing an additional 308,770 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Huron Consulting Group by 51.8% during the fourth quarter. Principal Financial Group Inc. now owns 476,863 shares of the business services provider’s stock worth $82,454,000 after purchasing an additional 162,706 shares in the last quarter. Boston Partners boosted its position in shares of Huron Consulting Group by 17.0% in the third quarter. Boston Partners now owns 888,045 shares of the business services provider’s stock worth $130,803,000 after buying an additional 129,073 shares during the period. Finally, Capital International Investors grew its stake in shares of Huron Consulting Group by 964.2% in the fourth quarter. Capital International Investors now owns 98,443 shares of the business services provider’s stock valued at $17,022,000 after buying an additional 89,193 shares in the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Insider Activity

In other news, insider Kyle Featherstone sold 459 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $152.67, for a total transaction of $70,075.53. Following the completion of the transaction, the insider directly owned 1,050 shares of the company’s stock, valued at approximately $160,303.50. This represents a 30.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO C. Mark Hussey sold 24,072 shares of the stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $165.59, for a total value of $3,986,082.48. Following the sale, the chief executive officer owned 74,399 shares in the company, valued at $12,319,730.41. The trade was a 24.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 27,393 shares of company stock valued at $4,370,677 over the last quarter. 2.07% of the stock is owned by company insiders.

Huron Consulting Group Price Performance

Shares of HURN stock opened at $149.68 on Thursday. The firm has a fifty day moving average of $111.36 and a two-hundred day moving average of $126.39. The firm has a market cap of $2.38 billion, a P/E ratio of 22.41 and a beta of 0.06. Huron Consulting Group Inc. has a 1-year low of $84.88 and a 1-year high of $186.77. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.71 and a quick ratio of 1.71.

Huron Consulting Group (NASDAQ:HURN) last issued its earnings results on Tuesday, July 28th. The business services provider reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.17 by $0.29. Huron Consulting Group had a net margin of 6.38% and a return on equity of 32.33%. The business had revenue of $475.04 million for the quarter, compared to analyst estimates of $448.98 million. During the same quarter in the prior year, the business posted $1.89 EPS. The company’s revenue for the quarter was up 15.7% on a year-over-year basis. Huron Consulting Group has set its FY 2026 guidance at 9.000-9.400 EPS. As a group, research analysts anticipate that Huron Consulting Group Inc. will post 9.18 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on HURN shares. Wall Street Zen raised Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Barrington Research reissued an “outperform” rating on shares of Huron Consulting Group in a research report on Wednesday, June 17th. Zacks Research upgraded shares of Huron Consulting Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, July 29th. Wedbush reaffirmed an “outperform” rating and set a $160.00 price target on shares of Huron Consulting Group in a report on Wednesday, May 6th. Finally, Weiss Ratings downgraded shares of Huron Consulting Group from a “hold (c+)” rating to a “hold (c)” rating in a research note on Tuesday, May 12th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $184.25.

About Huron Consulting Group

Huron Consulting Group (NASDAQ:HURN) is a global professional services firm that advises organizations across a range of industries on strategy, operations and technology. Founded in 2002 and headquartered in Chicago, the company helps clients address complex business challenges such as performance improvement, digital transformation and organizational change. Huron’s consultants work alongside executive leadership teams to develop and implement tailored solutions that drive growth, increase efficiency and manage risk.

Huron’s service offerings encompass business and financial advisory, healthcare performance improvement, life sciences consulting, higher education and research lifecycle support, as well as legal and regulatory consulting.